ncRNA name
CircFAT1
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-525-5p/SKA1
Cancer name
Breast Cancer
Cancer site
qRT-PCR,Western blot,Luciferase assay
Treatment type
Chemotherapy
Drug
Oxaliplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Down
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
40(<=50)+26(>50)
Age range and number
Not available
PMID
Description
our results demonstrated that circFAT1 conferred OX resistance in BC by regulating the miR-525-5p/SKA1 via the Notch and Wnt pathway
Tissue resource
breast cancer tissues
human breast epithelial cell lines MCF-10A
Experiment
66
Institute
Changzhou No.2 People’s Hospital Affiliated to Nanjing Medical University
BeNa Culture Collection
Country
China
China
Continent
Asia
Asia